Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.3M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
32.2M
-
Shares change
-
+345K
-
Total reported value, excl. options
-
$87.8M
-
Value change
-
+$896K
-
Number of buys
-
35
-
Number of sells
-
-37
-
Price
-
$2.73
Significant Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q1 2019
88 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock as of Q1 2019.
ENZO BIOCHEM INC - Common Stock (ENZB) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.2M shares
of 52.3M outstanding shares and own 61.52% of the company stock.
Largest 10 shareholders include Evermore Global Advisors, LLC (4.59M shares), WELLINGTON MANAGEMENT GROUP LLP (4.28M shares), BlackRock Inc. (3.92M shares), RENAISSANCE TECHNOLOGIES LLC (3.19M shares), HARBERT FUND ADVISORS, INC. (3.03M shares), VANGUARD GROUP INC (2.17M shares), DIMENSIONAL FUND ADVISORS LP (2.1M shares), Roumell Asset Management, LLC (1.9M shares), STATE STREET CORP (742K shares), and NORTHERN TRUST CORP (555K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.